After analyzing clinical data and performing validation in patient tumors, we identified a strong association between VCAN and survival in UTUC as well as the ability to distinguish LVI(+) from LVI(−) through tissue analysis. This evidence concerns the gene VCAN and renal pelvis/ureter urothelial carcinoma.